Global Health Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
No of Months
12
12
12
12
12
12
Profit Before Tax
449.00
280.00
32.00
63.00
83.00
59.00
Adjustment
198.00
195.00
189.00
165.00
146.00
125.00
Changes In working Capital
102.00
-66.00
36.00
2.00
2.00
-69.00
Cash Flow after changes in Working Capital
750.00
409.00
258.00
231.00
233.00
116.00
Cash Flow from Operating Activities
644.00
311.00
241.00
175.00
165.00
62.00
Cash Flow from Investing Activities
-342.00
-420.00
-239.00
-87.00
-248.00
-69.00
Cash Flow from Financing Activities
345.00
159.00
-80.00
0.00
97.00
9.00
Net Cash Inflow / Outflow
647.00
49.00
-78.00
87.00
13.00
2.00
Opening Cash & Cash Equivalents
119.00
69.00
147.00
60.00
46.00
43.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
767.00
119.00
69.00
147.00
60.00
46.00
Compare Cash Flow Results of Global Health
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
449.29
789.62
-340.00
-43.10%
Adjustment
198.55
383.67
-185.00
-48.25%
Changes In working Capital
102.82
-15.47
117.00
764.64%
Cash Flow after changes in Working Capital
750.66
1157.82
-407.00
-35.17%
Cash Flow from Operating Activities
644.52
1066.6
-422.00
-39.57%
Cash Flow from Investing Activities
-342.34
-1457.9
1,115.00
76.52%
Cash Flow from Financing Activities
345.64
488.45
-143.00
-29.24%
Net Cash Inflow / Outflow
647.81
97.15
550.00
566.81%
Opening Cash & Cash Equivalents
119.43
144.59
-25.00
-17.40%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
767.24
241.74
526.00
217.38%
Cash Flow - Snapshot (Standalone) - Mar'24
YoY Growth in year ended Mar 2024 is -20.88% vs 82.89% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
340.64
430.53
-20.88%